Here, we observed a trend to lower titers against SARS-CoV-2 spike variants in the oldest individuals at day 209, with marginally statistically significant differences in some assays for some variants.
← all excerpts
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
1
—
—